What’s a Normal Denial Rate? 2026 Benchmarks by Specialty

“Is our denial rate normal?” is one of the hardest questions in RCM to answer honestly, because the real answer is “normal compared to what, exactly?” Denial rate benchmarks get thrown around constantly, but most of them don’t say what population they’re measuring or how they define “denied” — which makes a lot of benchmark comparisons more misleading than useful. Here’s what’s actually solidly sourced, and how to use it without falling into that trap.

The industry anchor: AAFP and MGMA numbers

Two figures are worth treating as your baseline, because they come from named, credible sources rather than an aggregator blog:

• The American Academy of Family Physicians (AAFP) puts the general industry target at a 5–10% denial rate, with anything below 5% considered more desirable. AAFP itself notes this guidance doesn’t specify a particular population, sample, or data year, and uses a denied-dollars-over-submitted-dollars calculation that not every practice measures the same way.
• The Medical Group Management Association (MGMA) has reported an 8% first-submission denial rate across physician practices — a real, physician-practice-specific measurement that lines up with AAFP’s band.

If your practice sits meaningfully above roughly 10%, that’s a reasonable signal to dig in. If you’re under 5%, you’re in genuinely good shape by this anchor.

Specialty ranges (with an honest caveat)

Specialty-level denial rate figures circulate widely in industry content, generally clustering in these ranges:

• Primary care, dermatology, orthodontics: roughly 5–12%
• Pediatrics, urgent care, urology, oncology: roughly 7–15%
• Internal medicine, OB/GYN, neurology, gastroenterology, behavioral health: roughly 8–16%
• Orthopedics, cardiology, pain management: roughly 10–20%
• Emergency medicine, radiology/imaging, ambulatory surgery centers: roughly 12–22%, the highest of the commonly-cited ranges

We’re presenting these as directional ranges rather than precise figures on purpose — unlike the AAFP/MGMA numbers above, we couldn’t trace these specialty-level splits back to a single named, methodologically transparent source (MGMA and HFMA don’t appear to publish a public specialty-by-specialty breakdown at this granularity). Treat them as “here’s roughly where your specialty tends to land relative to others,” not as a number to hold your own practice to precisely.

Why comparing to an external benchmark can be misleading

Hospital denial rates, physician-practice denial rates, and payer-reported denial rates are three different metrics measured on three different populations — comparing your practice’s number to the wrong one is arguably worse than having no benchmark at all. Before you compare your rate to any of the numbers above, confirm you’re actually measuring the same thing: denied dollars vs. submitted dollars, or denied claim count vs. submitted claim count; first-submission denials only, or denials after resubmission too; gross denials, or denials net of the ones you successfully overturned on appeal.

What to actually do with this data

Use the AAFP/MGMA 5–10% band as your first gut check, use the specialty ranges to set rough expectations rather than hard targets, and build your real tracking around your own consistent, well-defined internal metric. If your specialty typically runs higher (radiology, ASCs, emergency medicine), don’t panic at a rate that would be alarming for a primary care practice — and don’t get complacent at a rate that looks fine for your specialty but is trending upward month over month.

Takeaway

The only denial rate benchmark solidly backed by a named source puts the general target at 5–10%, per AAFP and MGMA. Specialty-level figures are useful directionally but shouldn’t be treated as precise external targets. The single most reliable comparison is still your own practice’s trend over time, measured the same way every period.